Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 1,240 | 1,854 | 506 | 151 | 73 |
| Gross Profit | 1,240 | 1,854 | 506 | 151 | 73 |
| Operating Expenses | 4,491 | 3,344 | 5,228 | 5,723 | 5,167 |
| Operating Income | -3,251 | -1,490 | -4,722 | -5,572 | -5,094 |
| Interest Expense | 87 | 112 | 134 | 159 | 173 |
| Other Income | 119 | 120 | 51 | 73 | 48 |
| Pre-tax Income | -3,219 | -1,482 | -4,805 | -5,658 | -5,219 |
| Net Income Continuous | -3,219 | -1,482 | -4,805 | -5,658 | -5,219 |
| Net Income | $-3,219 | $-1,482 | $-4,805 | $-5,658 | $-5,219 |
| EPS Basic Total Ops | -25.00 | -14.75 | -51.75 | -58.04 | -71.25 |
| EPS Basic Continuous Ops | -24.95 | -14.77 | -51.78 | -57.59 | -71.34 |
| EPS Diluted Total Ops | -25.00 | -14.75 | -51.75 | -58.04 | -71.25 |
| EPS Diluted Continuous Ops | -24.95 | -14.77 | -51.78 | -57.59 | -71.34 |
| EBITDA(a) | $-3,051 | $-1,277 | $-4,498 | $-5,333 | $-4,845 |